Your browser doesn't support javascript.
loading
Rare germline structural variants increase risk for pediatric solid tumors.
Gillani, Riaz; Collins, Ryan L; Crowdis, Jett; Garza, Amanda; Jones, Jill K; Walker, Mark; Sanchis-Juan, Alba; Whelan, Chris; Pierce-Hoffman, Emma; Talkowski, Michael; Brand, Harrison; Haigis, Kevin; LoPiccolo, Jaclyn; AlDubayan, Saud H; Gusev, Alexander; Crompton, Brian D; Janeway, Katie A; Van Allen, Eliezer M.
Afiliação
  • Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Collins RL; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Crowdis J; Harvard Medical School, Boston, MA, USA.
  • Garza A; Boston Children's Hospital, Boston, MA, USA.
  • Jones JK; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Walker M; Harvard Medical School, Boston, MA, USA.
  • Sanchis-Juan A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Whelan C; Harvard Medical School, Boston, MA, USA.
  • Pierce-Hoffman E; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Talkowski M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Brand H; Harvard Medical School, Boston, MA, USA.
  • Haigis K; Boston Children's Hospital, Boston, MA, USA.
  • LoPiccolo J; Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • AlDubayan SH; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Gusev A; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Crompton BD; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Janeway KA; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Van Allen EM; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
bioRxiv ; 2024 Apr 29.
Article em En | MEDLINE | ID: mdl-38746320
ABSTRACT
Pediatric solid tumors are rare malignancies that represent a leading cause of death by disease among children in developed countries. The early age-of-onset of these tumors suggests that germline genetic factors are involved, yet conventional germline testing for short coding variants in established predisposition genes only identifies pathogenic events in 10-15% of patients. Here, we examined the role of germline structural variants (SVs)-an underexplored form of germline variation-in pediatric extracranial solid tumors using germline genome sequencing of 1,766 affected children, their 943 unaffected relatives, and 6,665 adult controls. We discovered a sex-biased association between very large (>1 megabase) germline chromosomal abnormalities and a four-fold increased risk of solid tumors in male children. The overall impact of germline SVs was greatest in neuroblastoma, where we revealed burdens of ultra-rare SVs that cause loss-of-function of highly expressed, mutationally intolerant, neurodevelopmental genes, as well as noncoding SVs predicted to disrupt three-dimensional chromatin domains in neural crest-derived tissues. Collectively, our results implicate rare germline SVs as a predisposing factor to pediatric solid tumors that may guide future studies and clinical practice.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article